{"url_path":"/sec/bpth/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000156-index.html","accession_number":"0001663577-26-000156","cik":"0001133818","ticker":"BPTH","issuer_name":"BIO-PATH HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000156-index.html","primary_entity_key":"0001133818","primary_entity_name":"BIO-PATH HOLDINGS, INC."},"word_count":703,"has_tables":true,"body_markdown":"**ITEM 6. EXHIBITS**\n\n \n \n\n**Exhibit No.**\n \n**Description of Exhibit**\n\n2.1\n \n[Agreement and Plan of Merger and Reorganization dated September 27, 2007, by and among the Company, Biopath Acquisition Corp., a Utah corporation and wholly owned subsidiary of the registrant, and Bio-Path, Inc., a Utah corporation (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 27, 2007).](https://www.sec.gov/Archives/edgar/data/1133818/000101619307000027/ex2-1.htm)\n\n3.1\n \n[Certificate of Incorporation (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 6, 2015).](https://www.sec.gov/Archives/edgar/data/1133818/000114420415000776/v398162_ex3-3.htm)\n\n3.2\n \n[Certificate of Amendment to the Certificate of Incorporation of Bio-Path Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 9, 2018).](https://www.sec.gov/Archives/edgar/data/1133818/000114420418006765/tv485337_ex3-1.htm)\n\n3.3\n \n[Certificate of Amendment to the Certificate of Incorporation of Bio-Path Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 16, 2019).](https://www.sec.gov/Archives/edgar/data/1133818/000114420419001872/tv511127_ex3-1.htm)\n\n3.4\n \n[Certificate of Amendment to the Certificate of Incorporation of Bio-Path Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 23, 2024).](https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/bpth-20240221xex3d1.htm)\n\n3.5\n \n[First Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 7, 2017).](https://www.sec.gov/Archives/edgar/data/1133818/000114420417031532/v468617_ex3-1.htm)\n\n3.6\n \n[Amendment No. 1 to the First Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 8, 2023).](https://www.sec.gov/Archives/edgar/data/1133818/000155837023019691/bpth-20231207xex3d1.htm)\n\n4.1\n \n[Promissory Note, dated as of April 28, 2025, issued by the Company in favor of the Second Lender (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 29, 2025).](https://www.sec.gov/Archives/edgar/data/1133818/000110465925041256/tm2513536d1_ex4-1.htm)\n\n10.1\n \n[Securities Purchase Agreement, dated as of April 28, 2025, by and between the Company and the Second Lender (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 29, 2025).](https://www.sec.gov/Archives/edgar/data/1133818/000110465925041256/tm2513536d1_ex10-1.htm)\n\n10.2\n \n[Second Amendment to Lease Agreement, dated April 10, 2025, by and between the Company and HJF Properties, LLC (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 15, 2025).](https://www.sec.gov/Archives/edgar/data/1133818/000155837025007887/bpth-20250331xex10d3.htm)\n\n10.3\n \n[Bio-Path Holdings, Inc. Domestication to Wyoming 02/05-2026 (Incorporated by reference to Form 8-K filed March 20, 2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000064/ex10_1.htm)\n\n10.4\n \n[Amendment to Bio-Path Holdings, Inc. Articles of Incorporation: Creation of Series S Preferred Stock 01-02-2026 (Incorporated by reference to Form 8-K filed March 20, 2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000064/ex10_2.htm)\n\n10.5\n \n[Vanquish Funding Group Inc. Promissory Note: 12/29/2025 (Incorporated by reference to Form 1-A filed 03/25/2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000075/ex10_3.htm)\n\n10.6\n \n[Quick Capital LLC Promissory Note: 01/02/2026 (Incorporated by reference to Form 1-A filed 03/25/ 2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000075/ex10_4.htm)\n\n10.7\n \n[Bio-Path Holdings, Inc. Steel Giants Advisors LLC Consulting Agreement: 10/24/2025 (Incorporated by reference to Form 1-A filed 03/25/2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000075/ex10_5.htm)\n\n10.8\n \n[Steel Giants Advisors LLC Warrant: 01/02/2026 (Incorporated by reference to Form 1-A filed 03/25/2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000075/ex10_6.htm)\n\n10.9\n \n[Series S Preferred stock certificate of determination (Incorporated by reference to Form 1-K filed 05/01/2026)](https://www.sec.gov/Archives/edgar/data/1133818/000166357726000123/ex10_7.htm)\n\n31*\n \n[Certification of Principal Executive Officer and Principal Financial Officer pursuant to Exchange Act Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 Sarbanes Oxley Act of 2002.](ex31.htm)\n\n32**\n \n[Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.](ex32.htm)\n\n101*\n \nThe following financial statements from the Company’s\nQuarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets\n(Unaudited); (ii) Condensed Consolidated Statements of Operations (Unaudited); (iii) Condensed Consolidated Statements of Cash Flows\n(Unaudited); (iv) Condensed Consolidated Statements of Shareholders’ Equity (Unaudited); and (v) Notes to the Unaudited Condensed\nConsolidated Financial Statements, tagged as blocks of text and including detailed tags.\n\n104*\n \nThe cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL (included as Exhibit 101).\n\n* Filed herewith.\n\n** Furnished herewith.\n\n \n\n 26 \n\n[Table of Contents](#toc) \n\n \n\n**SIGNATURE**\n\nPursuant to the requirements of the Securities Exchange\nAct of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n \n \n\nDated:\nMay 20, 2026\nBIO-PATH HOLDINGS, INC.\n\n \n \n\n \nBy:\n/s/ Vikram Grover\n\n \n \nVikram Grover\n\n \n \n\nChief Executive Officer\n\n(Principal Executive Officer)\n\nChief Financial Officer\n\n(Principal Financial Officer)\n\n 27 \n\n[Table of Contents](#toc)"}